By continuing to browse this site, you agree to the use of cookies to enhance your user experience:
read our legal notice and privacy policy.

I understood
 
 
Centre de Cancérologie de la Porte de Saint-Cloud
  •  
Homepage  /   Quality and safety  /
The oncology center
Presentation and history Quality and safety Testimonials Organisation chart HR policy and recruitment Key figures and indicators
The medical team
Presentation of the medical team A tailored approach to cancer care Coordination with your GP Making an appointment
The treatments
Organisation of oncology care Radiotherapy Gyroscopic radiosurgery Chemotherapy Medical oncology hospitalisation Glossary
Patient support
Announcing the diagnosis Special paramedical consultation Pain management Nutritional consultation Psychological consultation Social welfare Beauty advisor
Practical information
How to find us Your admission Your stay Going home Medical factsheets
Networks and partners The Cancer Care initiative Research and publications
Contacts

Click on a department in the list below to send
an e-mail directly to the service required...

Center switchboard Reception, admissions, appointments
Radiotherapy Chemotherapy Medical hospitalisation Pharmacy
Service users’ representative
For any medical question

... or click here to access
the nominative list of contacts

Ensuring patient safety

To ensure that you are provided with quality treatments in optimum conditions of safety, the “Centre de Cancérologie de la Porte de Saint-Cloud” has set up an organisation based on a vigilance system.

Health vigilance systems

An in-house liaison officer, a healthcare professional, has been appointed for each healthcare vigilance system:

  • Haemovigilance is part of the blood transfusion safety system: it deals with monitoring, assessment and prevention of incidents and undesirable effects occurring in donors and recipients of labile blood products.
  • Identity vigilance prevents any errors and risks that might arise from incorrect patient identification.
  • HAI vigilance uses a system of alerts and reporting to monitor major risks of infection in healthcare establishments in order to prevent any nosocomial transmission. This vigilance contributes to the fight against hospital-acquired infections and the emergence and dissemination of multi-resistant bacteria. It forms part of the safety and quality measures regarding treatments given to patients.
  • Medical devices vigilance aims to avoid the occurrence and recurrence of incidents and risks of serious incidents (as defined in Article L.5242-2 of the French Public Health Code) involving medical devices by taking appropriate preventive and/or corrective measures.
  • Pharmacovigilance is the process of monitoring the safety and preventing the risk of undesirable effects of medicines, whether the risk is potential or proven.


For more information about health vigilance systems, click here.

The Vigilance and Risk Management Committee (COVIRIS)

These vigilance liaison officers are members of the Vigilance and Risk Management Committee (COVIRIS) and they are tasked with defining priorities for risk management and coordinating the various resources involved in risk prevention and management.

Other bodies also participate in this risk management policy, such as the radiotherapy and drug circuit feedback unit (CREX), the mortality and morbidity review (RMM) and the patient identity vigilance unit (CIV).

Directions   I   Legal Notice
Centre de Cancérologie de la Porte de Saint-Cloud - 30, rue de Paris, 92100 Boulogne-Billancourt       Tel. +33 1 41 10 27 27
© 2026 Centre de Cancérologie de la Porte de Saint-Cloud   /   Last updated 04-24, 2026   /   Webdesign & Photos credit: Mediaction, Paris - Powered by doxFinder™